合成目标产物 Erythorbic Acid 主要起始原料 Hydrochloric Acid And 2-Oxogluconic Acid And Water
50271-42-6 = 89-65-6 反应条件:1.1 Reagents: Water Catalysts: Antimony Trichloride Solvents: Acetonitrile; 20 Min,Rt 标题:Mild,Efficient And Highly Selective Hydrolysis Of Acetonides With Antimony Trichloride 作者:Wu,Qinpei; Chen,Wei; Wang,Yuan; Qu,Yunbo; Zhang,Qingshan 参考文献:Letters In Organic Chemistry 日期:2006 卷标:3(4) 页码:271-274]
114559-95-4 = 89-65-6 反应条件:1.1 Reagents: Hydrochloric Acid,Water Solvents: Ethanol,1,2-Dichloroethane 标题:Mechanism Of Transformation Of Diacetone-2-Keto-L-Gulonic Acid Into Ascorbic Acid 作者:Berezovskii,V. M.; Strel'Chunas,L. I. 参考文献:Zhurnal Obshchei Khimii 日期:1950 卷标:20 页码:2072-5]
50271-42-6 = 89-65-6 反应条件:1.1 Catalysts: Methanesulfonic Acid,1,1,1-Trifluoro-,Erbium(3+) Salt (3:1) Solvents: Water; 5 Min,120 °C 标题:Mw-Assisted Er(Otf)3-Catalyzed Mild Cleavage Of Isopropylidene Acetals In Tricky Substrates 作者:Procopio,Antonio; Gaspari,Marco; Nardi,Monica; Oliverio,Manuela; Romeo,Roberto 参考文献:Tetrahedron Letters 日期:2008 卷标:49(12) 页码:1961-1964]
669-90-9 = 89-65-6 反应条件:1.1 Catalysts: Chlorosulfonic Acid Solvents: Water; 1 H,100 °C 标题:Synthesis Of Isoascorbic Acid Directly From 2-Keto-Gluconic Acid 作者:Zheng,Dagui; Ye,Hongde; Yu,Silian; Ye,Qing; Xie,Guohao; Et Al 参考文献:Shipin Gongye Keji 日期:2004 卷标:25(7) 页码:115-117
Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于甲醇,硫酸,水体系中,化学反应生成 D-异抗坏血酸 参考文献:Method For The Production Of Saccharosonic Acids And Their Salts 标题:Method For The Production Of Saccharosonic Acids And Their Salts
专利号:US-9233943-B2 优先权日:2012-01-10 标题:Process for synthesis of syn azido epdxide and its use as intermediate for the synthesis of amprenavir and saquinavir 发明人:GADAKH SUNITA KHANDERAO; REKULA REDDY SANTHOSH; SUDALAI ARUMUGAM 权利人:COUNCIL SCIENT IND RES 摘要:A novel synthetic route to the syn-azido epoxide of formula 5 includes cobalt-catalyzed hydrolytic kinetic resolution of a racemic mixture of the azido-epoxide. Reaction steps include subjecting an allylic alcohol to epoxidation with mCPBA to obtain a racemic epoxy alcohol; ring opening the epoxy alcohol with azide anion to obtain an anti-azido alcohol, which can then be selectively tosylated at the primary alcohol; treating the tosylate with base to obtain the racemic azido-epoxide; and subjecting the racemic azido-epoxide to cobalt-catalyzed hydrolytic kinetic resolution to obtain the syn-azido epoxide of formula 5. The compound of formula 5 may be used as a common intermediate for the asymmetric synthesis of HIV protease inhibitors, such as Amprenavir, Fosamprenavir, Saquinavir, and formal synthesis of Darunavir and Palinavir.
专利号:US-12018313-B2 优先权日:2016-12-28 标题:Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles 发明人:EMBREE MALLORY 权利人:NATIVE MICROBIALS INC 摘要:Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles, including dosed microbial ensembles and inoculative microbial ensembles, are disclosed.
专利号:US-5656662-A 优先权日:1990-01-12 标 题:Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids 发明人:MANTRI PADMAJA; WITIAK DONALD T 权利人:UNIV OHIO STATE RES FOUND 摘要:The present invention relates to a method for synthesis of optically pure 4-alkenyl or 4-alkanyl-2-hydroxytetronic acids from an optically pure aldehyde. The invention further relates to the use of such optically pure compounds as potent inhibitors of platelet aggregation by working at the level of cyclooxygenase, thus making them useful in the treatment of coronary artery diseases, especially atherosclerosis, and additionally, as inhibitors of various inflammatory cytokines, making them useful in the treatment of both acute and chronic inflammation, as well in the treatment of cachexia, rheumatoid arthritis, multiple sclerosis, Crohn's disease and ulcerative colitis. The invention further relates to pharmaceutical compositions of the instant compounds.
专利号:US-4557866-A 优先权日:1984-05-15 标 题 :Process for the synthesis of pyrido-imidazo rifamycins 发明人:CANNATA VINCENZO; TAMAGNONE GIAN F 权利人:ALFA FARMACEUTICI SPA 摘要:A new process for the synthesis of pyrido-imidazo-rifamycins of formula I wherein R is hydrogen or acetyl, R1 and R2 independently represent hydrogen, (C1-4)-alkyl, benzyloxy, mono- or di-(C1-3)-alkylamino-(C1-4)-alkyl, (C1-3)-alkoxy-(C1-4)-alkyl, hydroxymethyl, hydroxy-(C2-4)-alkyl, cyano, halogen, nitro, mercapto, (C1-4)-alkylthio, phenylthio, carbamoyl, mono- or di-(C1-4)-alkyl-carbamoyl, or R1 and R2 taken together with two consecutive carbon atoms of the pyridine nucleus form a benzene ring optionally substituted by one or two methyl or ethyl groups. The process comprises reacting the rifamycin O of formula II with a 2-aminopyridine of formula III wherein R1 and R2 have the same meanings as before.
专利号:WO-0172706-A1 优先权日:2000-03-28 标题 :Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) 发明人:SAMBASIVAN GANESH; SRIDHARAN MADHAVAN; PADUDEVASTANA SATHYASHANKER; POORNAPRAJNA ACHARYA; MATHEW JOY; SRINATH SUMITHRA; NAIR SATHEESH 权利人:BIOCON LTD; SAMBASIVAN GANESH; SRIDHARAN MADHAVAN; PADUDEVASTANA SATHYASHANKER; POORNAPRAJNA ACHARYA; MATHEW JOY; SRINATH SUMITHRA; NAIR SATHEESH 摘要:The present invention discusses a novel process for the synthesis of [R-(R*,R*)]-2-(4-fluorophenyl)-B,D-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt by using 4-fluoro-α-[2-methyl-1-oxopropyl]η-oxo-N-β-diphenylbenzene butaneamide with (4R)-methyl 6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-3-acetate. The compound so prepared is useful as inhibitors of the enzyme HMG-CoA reductase and are thus used as hypolipidemic and hypocholesterolemic agents.
专利号:US-6867306-B2 优先权日:2001-01-19 标题:Process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds 发明人:SRINATH SUMITRA; MATHEW JOY; UJIRE SANDHYA; SRIDHARAN MADHAVAN; SAMBASIVAM GANESH 权利人:BIOCON LTD 摘要:The present invention discusses a novel process for the synthesis of [R-(R*,R*)]-2-(4-fluorophenyl)-B,D-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium, atorvastatin. The compound so prepared is useful as inhibitor of the HMG-CoA reductase and may thus be used as hypolipidemic and hypocholesterolemic agent.
1: Raj PS, Bergfeld WF, Belsito DV, Cohen DE, Klaassen CD, Liebler DC, Rettie AE, Ross D, Slaga TJ, Snyder PW, Tilton S, Fiume M, Heldreth B. Erythorbic Acid and Sodium Erythorbate. Int J Toxicol. 2023 Dec;42(3_suppl):37S-39S. doi: 10.1177/10915818231204257. Epub 2023 Sep 28. 79(1):99-102. doi: 10.1093/ajcn/79.1.99.
合成参考文献
摘要:Rowe, R.C., Sheskey, P.J., Quinn, M.E.; (Eds.), Handbook of Pharmaceutical Excipients 6th edition Pharmaceutical Press, London, England 2009, p. 251 摘要:NIOSH; NOES. National Occupational Exposure Survey conducted from 1981-1983. Estimated numbers of employees potentially exposed to specific agents by 2-digit standard industrial classification (SIC). Available from, as of April 27, 2010: 摘要:21 CFR 182.3041 (USFDA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of July 28, 2010: 摘要:Franke C et al; Chemosphere 29: 1501-14 (1994) 摘要:WHO; Food Additives Series 28 (1991). Available from, as of August 6, 2010: https://www.inchem.org/documents/jecfa/jecmono/v28je03.htm